Bills › 132nd Legislature (2025–26)
LD 180
An Act Regarding The Interactions Of Pharmacy Benefits Managers And So-Called 340B Entities And Reimbursements By Pharmacy Benefits Managers To Pharmacies
Became law · sponsored by Kristi Mathieson · text and history at the Legislature
Who lobbied on it
13 clients whose lobbyists named LD 180 in their monthly reports, with the pay they attributed to it (not their position). Linked: clients who also gave to two or more 2026 candidates.
| Client | Lobbyists | Months | Pay attributed |
|---|---|---|---|
| Pharmaceutical Research and Manufacturers of America (PhRMA) | Ann Robinson, Jim Mitchell | 8 | $1,354.84 |
| Association for Accessible Medicines | Jonathan Courtney | 3 | $0 |
| AstraZeneca Pharmaceuticals, LP | Holly Lusk | 1 | $0 |
| CIGNA | Charles C. Soltan | 6 | $0 |
| Elevance Health, Inc., and its affiliates including Anthem Health Plans of Maine | Kristine Ossenfort | 2 | $0 |
| Eli Lilly & Company | Ann Mitchell | 3 | $0 |
| Healthcare Purchaser Alliance of Maine | Lisa Nolan | 3 | $0 |
| Maine Association of Health Plans | Dan Demeritt | 2 | $0 |
| Maine Hospital Association | Jeffrey Austin | 1 | $0 |
| Maine Pharmacy Association | Amy Downing | 1 | $0 |
| Pharmaceutical Care Management Association | Sam Hallemeier | 1 | $0 |
| Retail Association of Maine | Curtis Picard | 3 | $0 |
| Viatris, Inc. | Edward Pineau | 2 | $0 |